SALONI WAGH
Supriya Lifescience to bet on R&D, expansion to grow revenuesSupriya Lifescience, an active pharmaceutical ingredient (API) maker based in Mumbai, aims to double its revenue in the next three years. T...20 Dec, 2023, 12.24 AM IST
Supriya Lifescience to sustain 40% plus EBITDA margin going forward: Saloni Wagh“Our business model is completely derisked and the company has very strong fundamentals. Whatever percentage of growth we have seen in the ...28 Dec, 2021, 05.01 PM IST
Load More